Pendal Group’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
$7.35M Sell
20,089
-4,339
-18% -$1.54M 0.06% 127
2022
Q3
$7.9M Buy
24,428
+22,463
+1,143% +$7.12M 0.08% 116
2022
Q2
$637K Sell
1,965
-328
-14% -$98.5K 0.01% 319
2022
Q1
$657K Sell
2,293
-12
-0.5% -$3.09K 0.01% 373
2021
Q4
$637K Sell
2,305
-6,776
-75% -$1.72M 0.01% 389
2021
Q3
$2.1M Buy
9,081
+5,061
+126% +$1.25M 0.02% 224
2021
Q2
$923K Buy
4,020
+1,021
+34% +$205K 0.01% 341
2021
Q1
$560K Sell
2,999
-4,518
-60% -$884K 0.01% 393
2020
Q4
$1.27M Sell
7,517
-2,802
-27% -$418K 0.01% 261
2020
Q3
$1.53M Buy
10,319
+5,566
+117% +$861K 0.02% 203
2020
Q2
$780K Buy
4,753
+1,018
+27% +$156K 0.01% 264
2020
Q1
$518K Sell
3,735
-2,107
-36% -$290K 0.01% 273
2019
Q4
$768K Sell
5,842
-27,126
-82% -$3.14M 0.01% 276
2019
Q3
$3.69M Sell
32,968
-52,351
-61% -$5.83M 0.05% 144
2019
Q2
$9.45M Buy
85,319
+76,912
+915% +$9.06M 0.13% 79
2019
Q1
$1.09M Sell
8,407
-48,560
-85% -$5.9M 0.02% 283
2018
Q4
$6.59M Buy
+56,967
New +$6.36M 0.11% 108
2018
Q2
Sell
-728
Closed -$56.3K 475
2018
Q1
$56.3K Hold
728
﹤0.01% 452
2017
Q4
$61.5K Sell
728
-12,731
-95% -$1.08M ﹤0.01% 449
2017
Q3
$1.15M Sell
13,459
-21,983
-62% -$1.8M 0.02% 292
2017
Q2
$2.92M Buy
+35,442
New +$2.89M 0.04% 207

Other funds holding LLY

Pendal Group's LLY Position: Q4 2022 in Review

Pendal Group reduced its Eli Lilly (LLY) stake by 18% in Q4 2022, selling an estimated $1.54M and leaving 20,089 shares worth $7.35M. The position accounts for 0.06% of the portfolio, ranked #127.

Pendal Group first reported a position in LLY in Q2 2017 and has held it in 21 quarters since. The position peaked at $9.45M in Q2 2019. 2,671 funds tracked by Wall St. Rank hold LLY as of Q4 2022.

  • Pendal Group held 20,089 shares of Eli Lilly worth $7.35M as of Q4 2022.
  • Pendal Group sold 4,339 Eli Lilly shares in Q4 2022, an estimated $1.54M.
  • Eli Lilly made up 0.06% of Pendal Group's portfolio in Q4 2022, its #127 holding.
  • Pendal Group first reported a position in Eli Lilly in Q2 2017 and has held it in 21 quarters since.
  • Pendal Group's Eli Lilly position peaked at $9.45M in Q2 2019.
  • 2,671 funds tracked by Wall St. Rank held Eli Lilly as of Q4 2022.

Based on Pendal Group's 13F filing for Q4 2022, filed 19 Jan 2023.